News
-
-
PRESS RELEASE
Inside Information / Other news releases
-
PRESS RELEASE
Informations privilégiées / Autres communiqués
-
-
-
PRESS RELEASE
EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3Y - Change of Directors Interest Notice
Dexus Finance Pty Limited releases Appendix 3Y on Change of Director's Interest Notice for Rhoda Phillippo via ASX announcement. Dexus manages a $54.5 billion real estate and infrastructure portfolio -
-
-
PRESS RELEASE
Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting
Protagonist Therapeutics to present final data from Phase 2 REVIVE study on rusfertide in polycythemia vera at ASH 66th Annual Meeting. Company focus on late-stage biopharmaceutical development -